Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 482-130-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
not sensitising [based on results of a reliable OECD 406 study (guinea pig maximisation test) for 'Paraffin Waxes (Fischer-Tropsch), full range, C15-50 - branched and linear']
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was performed between 08 October 2007 and 08 November 2007.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Date of inspection: January 2007; Date of certificate: February 2007
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- justification for the use of another test: unfeasible
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Female albino Dunkin Hartley guinea pigs were supplied by Charles River (F-69592 L’Arbresle).
- Age at study initiation: 5 weeks old.
- Weight at study initiation: At the start of the main study the animals were in the weight range of 299 to 360 g
- Housing: The animals were housed in groups of two or three in makrolon cages furnished with woodflakes. The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
Free access to mains tap water and food (SDS, Essex UK, CM8 3AB) was allowed throughout the study. The diet, drinking water and bedding were routinely analysed and were considered not to contain any contaminant that could reasonably be expected to affect the purpose or integrity of the study.
- Acclimation period: At least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Set to achieve limits of 20 to 25 °C
- Humidity (%): Set to achieve limits of 30 to 53 %.
- Air changes (per hr): At least ten changes per hour.
- Photoperiod (hrs dark / hrs light): The lighting was controlled by a time switch to give twelve hours continuous light (07:00 to 19:00) and twelve hours darkness.
IN-LIFE DATES: From: 0 To: 26 - Route:
- intradermal and epicutaneous
- Vehicle:
- other: olive oil and liquid paraffin
- Concentration / amount:
- Sighting Tests:
Intrademeral Induction: 100 %, 50 %, 25 %, 12.5 %, 6.25 % and 3.125 % by successive dilution (v/v) in olive oil
Topical Induction: 100 %, 50 %, 25 % and 12.5 % by successive dilution (v/v) in liquid paraffin
Topical Challenge: 100 %, 50 %, 25% and 12.5 % by successive dilution (v/v) in liquid paraffin
Main study:
Test animals
Intradermal induction: 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride; 100 % substance (undiluted); 50 % substance (in 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride)
Topical induction: 100 % substance (undiluted)
Topical challenge: 100 % substance (undiluted) and 50 % (v/v) in liquid paraffin
Control animals
Negative control:
Intradermal induction: 100 % Vehicle (olive oil); 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride; 100 % (undiluted); 50 % (in 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride)
Topical induction: 100 % (undiluted)
Topical challenge: 100 % (undiluted) and 50 % (v/v) in liquid paraffin
Positive control: - Route:
- epicutaneous, occlusive
- Vehicle:
- other: olive oil and liquid paraffin
- Concentration / amount:
- Sighting Tests:
Intrademeral Induction: 100 %, 50 %, 25 %, 12.5 %, 6.25 % and 3.125 % by successive dilution (v/v) in olive oil
Topical Induction: 100 %, 50 %, 25 % and 12.5 % by successive dilution (v/v) in liquid paraffin
Topical Challenge: 100 %, 50 %, 25 % and 12.5 % by successive dilution (v/v) in liquid paraffin
Main study:
Test animals
Intradermal induction: 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride; 100 % substance (undiluted); 50 % substance (in 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride)
Topical induction: 100 % substance (undiluted)
Topical challenge: 100 % substance (undiluted) and 50 % (v/v) in liquid paraffin
Control animals
Negative control:
Intradermal induction: 100 % Vehicle (olive oil); 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride; 100 % (undiluted); 50 % (in 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride)
Topical induction: 100 % (undiluted)
Topical challenge: 100 % (undiluted) and 50 % (v/v) in liquid paraffin
Positive control: - No. of animals per dose:
- Sighting tests:
2 animals for induction concentrations.
3 animals for topical challenge concentrations.
Main study:
11 test animals and 5 control animals. - Details on study design:
- RANGE FINDING TESTS:
The concentrations of test material to be used at each stage of the main study were determined by 'sighting tests' in which groups of guinea pigs were treated with various concentrations of test material. The procedures were as follows:
Selection of Concentration for Intradermal Induction:
Intradermal injections (0.1 ml / injection site) were made on the clipped shoulder of two guinea pigs, at the concentrations of 100 %, 50 %, 25 %, 12.5 %, 6.25 % and 3.125 % by successive dilution (v/v) in olive oil. A macroscopic evaluation of the injection sites was conducted approximately 24 hours after injection to determine whether these concentrations caused necrosis. Any evidence of systemic toxicity was also recorded. The highest concentration which did not cause necrosis was selected for the intradermal induction stage of the main study.
Selection of Concentration for Topical Induction:
Two guinea pigs were treated with preparations of the test material at 100 % and diluted at 50 %, 25 % and 12.5 % by successive dilution (v/v) in liquid paraffin. Applications were made to the clipped flanks under occlusive dressings for an exposure period of 24 hours. The degree of erythema and oedema was evaluated approximately 24 hours after dressing removal. The highest concentration producing only moderate dermal irritation was selected for the topical induction stage of the main study.
Selection of Concentration for Topical Challenge:
Four preparations of the test material at 100 % and diluted at 50 %, 25 % and 12.5 % by successive dilution (v/v) in liquid paraffin were applied to the clipped flanks of three guinea pigs under occlusive dressings for an exposure period of 24 hours. These guinea pigs did not form part of the
main study but had been treated identically to the control animals of the main study, up to Day 14.
The degree of erythema and oedema was evaluated approximately 24 hours after dressing removal. The highest non-irritant concentration of the test material and one lower concentration were selected for the topical challenge stage of the main study
MAIN STUDY
A. INDUCTION EXPOSURE
Induction of the Test Animals: Shortly before treatment on Day 0 the hair was removed from an area approximately 40 mm x 60 mm on the shoulder region of each animal with veterinary clippers. A row of three injections (0.1 ml each) was made on each side of the spine. The injections were:
a) Freund's Complete Adjuvant plus isotonic sodium chloride in the ratio 1:1
b) 100 % of the test material
c) a 50 % formulation of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus isotonic sodium chloride
On Day 7, the scapular region of all test and control animals was shaved.
On Day 8 the same area on the shoulder region used previously for intradermal injections was clipped again and treated with a topical application of the test material formulation. A topical application of the test material at 100 % under occlusive dressing was made. The occlusive dressing was kept in place for 48 hours.
The degree of erythema and oedema was evaluated approximately 24 hours after dressing removal.
Induction of the Control Animals: On Day 0, the intradermal induction was performed using an identical procedure to that used for the test animals except that the test material was omitted from the intradermal injections. Injection b) was therefore the vehicle alone, injection c) was a 50 % formulation of the vehicle in a 1:1 preparation of Freund’s Complete Adjuvant plus isotonic sodium chloride. Similarly, on Day 8, the topical induction procedure was identical to that used for the test animals except that the test material was omitted.
The degree of erythema and oedema was evaluated approximately 24 hours after dressing removal.
B. CHALLENGE EXPOSURE
The flanks of each animal were previously clipped free of hair with veterinary clippers.
The test material formulation at the maximum non-irritant concentration (100 %) was applied to one side of the shorn flank of each animal under an occlusive dressing. To ensure that the maximum non-irritant concentration was used at challenge, the test material at a concentration of 50 % (v/v) in liquid paraffin was similarly applied under an occlusive dressing to the opposite skin site on the shorn flank.
After 24 hours, the dressing was carefully removed and discarded. The topical challenge sites were cleaned if required.
Prior to the 24-hour observation the flanks were clipped to remove regrown hair.
Approximately 24 and 48 hours after challenge dressing removal, the degree of erythema and oedema was quantified using the scale shown below.
Any other reactions were also recorded.
Scales for Evaluation of Skin Reactions
EVALUATION OF ERYTHEMA
No visible modification: 0
Slight or patches of erythema: 1
Moderate confluent erythema: 2
Intense erythema and swelling: 3
EVALUATION OF OEDEMA
No visible modification: 0
Slight oedema: 1
Moderate oedema: 2
Severe oedema: 3
- Challenge controls:
- 5 female control animals were used for the topical challenge (100 % and 50 % in liquid paraffin).
- Positive control substance(s):
- yes
- Remarks:
- α-Hexylcinnamaldehyde (CAS [101-86-0])
- Positive control results:
- Under the conditions of the test, the Positive control material, α-Hexylcinnamaldehyde, was classified sensitisers according to EU labelling regulation
Please refer to attached background material for two skin sensitisation studies on the positive control substance, α-Hexylcinnamaldehyde, confirming the validity of the postive control substance as a sensitiser and the validity of the study method. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: No skin reaction.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: No skin reaction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% . No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: No skin reaction.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 11
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 11.0. Clinical observations: No skin reaction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No skin reaction.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No skin reaction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No skin reaction.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No skin reaction
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No skin reaction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50% α-hexylcinnamaldehyde
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- The most recent positive control test was carried out on 16/10/2007
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50% α-hexylcinnamaldehyde
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- The most recent positive control test was carried out on 16/10/2007
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25% α-hexylcinnamaldehyde
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- The most recent positive control test was carried out on 16/10/2007
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25% α-hexylcinnamaldehyde
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- The most recent positive control test was carried out on 16/10/2007
- Interpretation of results:
- other: EU GHS criteria not met
- Conclusions:
- Under the conditions of the test, the test material produced a 0 % sensitisation rate and was classified as a non-sensitiser to guinea pig skin.
The test material did not meet the criteria for classification as a sensitiser according to EU labelling regulations Commission Directive 2001/59/EC. No symbol and risk phrase are required. - Executive summary:
Introduction.
The study was performed to assess the contact sensitisation potential of the test material in the albino guinea pig. The method was designed to meet the requirements of the following:
- OECD Guidelines for the Testing of Chemicals No. 406 “Skin Sensitisation” (adopted 17 July 1992)
- Method B6 Acute Toxicity (Skin Sensitisation) of Commission Directive 96/54/EC
Method
Eleven test and five control animals were used for the main study. Two phases were involved in the main test; an induction of a response by intradermal injection and topical application and a topical challenge of that response. Based on the results of sighting tests, the concentrations of test material for the topical induction and topical challenge phases were selected as:
Intradermal Induction: 100 %
Topical Induction: 100 %
Topical Challenge: 100 % and 50 % in liquid paraffin
Conclusion
Under the conditions of the test, the test material produced a 0 % sensitisation rate and was classified as a non-sensitiser to guinea pig skin. The test material did not meet the criteria for classification as a sensitiser according to EU GHS criteria.
Reference
Preliminary Sighting Tests
Skin Reactions Observed After Intradermal Induction
A slight erythema was noted at the intradermal induction sites of the preliminary sighting test animals following treatment with the test material at the concentration of 100 % in two animals and at the concentration of 50 % in one animal. No skin reactions were noted at the intradermal inducion sites of the preliminary sighting test animals following treatment with the test material at the concentrations of 25 %, 12.5 %, 6.25 % and 13.125 %..
The concentration chosen for use in the intradermal induction phase of the main test was 100 % (maximal non necrotising concentration (MNNC)).
Skin Reactions Observed After Topical Induction
No skin reactions were noted at the topical induction sites of the preliminary sighting test animals following treatment with the test material at concentrations of 100 %, 50 %, 25 % and 12.5 %.
The concentration chosen for use in the 2nd topical induction of the main test was 100 % and the 1st concentration chosen for the MNIC (maximal non irritant concentration) determination was 100 %.
Skin Reactions Observed After Topical Challenge
No skin reactions were noted at the topical challenge sites of the preliminary sighting test animals following treatment with the test material at concentrations of 100 %, 50 %, 25 % and 12.5 %.
The concentrations chosen for use in the Topical Challenge phase of the main test were 100 % (maximal non irritant concentration (MNIC)) and 50 % (1/2 MNIC) in liquid paraffin.
Skin Reactions Observed After Topical Challenge 100%
No skin reactions were noted at the topical challenge site of the test or control group animals at the 24 and 48 -hour observations.
50% in liquid paraffin
No skin reactions were noted at the topical challenge site of the test or control group animals at the 24 and 48-hour observations.
Under the conditions of the test, the test material produced a 0 % sensitisation rate and was classified as a non-sensitiser to guinea pig skin.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The study was performed to assess the contact sensitisation potential of the test material in the albino guinea pig. The method was designed to meet the requirements of OECD Guideline No. 406 and EU-Method B.6.
The concentrations of test material for the topical induction and topical challenge phases were selected as:
- Intradermal Induction: 100%
- Topical Induction: 100%
- Topical Challenge: 100% and 50% in liquid paraffin.
Skin Reactions Observed After Topical Challenge
- 100%: No skin reactions were noted at the topical challenge site of the test or control group animals at the 24 and 48 -hour observations.
- 50% in liquid paraffin: No skin reactions were noted at the topical challenge site of the test or control group animals at the 24 and 48 -hour observations.
The test material produced a 0% sensitisation rate.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to CLP classification criteria, the substance does not meet the criteria for classification and labelling for this endpoint, as set out in Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.